GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Statera BioPharma Inc (STU:7CB) » Definitions » Total Payout Yield %

Statera BioPharma (STU:7CB) Total Payout Yield % : -30,261.90 (As of Jun. 23, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Statera BioPharma Total Payout Yield %?

Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.

Statera BioPharma's current Total Payout Yield % is -30,261.90%.


Statera BioPharma Total Payout Yield % Historical Data

The historical data trend for Statera BioPharma's Total Payout Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Statera BioPharma Total Payout Yield % Chart

Statera BioPharma Annual Data
Trend Dec19 Dec20 Dec21
Total Payout Yield %
- - -

Statera BioPharma Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Total Payout Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Statera BioPharma's Total Payout Yield %

For the Biotechnology subindustry, Statera BioPharma's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Statera BioPharma's Total Payout Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Statera BioPharma's Total Payout Yield % distribution charts can be found below:

* The bar in red indicates where Statera BioPharma's Total Payout Yield % falls into.



Statera BioPharma Total Payout Yield % Calculation

Total Payout Yield % is a measure of shareholder return.

Statera BioPharma's Total Payout Yield % for the fiscal year that ended in Dec. 2021 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Market Cap
=- (0 + 6.499 + 0) / 0
=N/A%

Statera BioPharma's annualized Total Payout Yield % for the quarter that ended in Sep. 2022 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) * Annualized Factor / Market Cap
=- (0 + 0 + 0) * 4 / 0
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Statera BioPharma Total Payout Yield % Explanation

Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.


Statera BioPharma Total Payout Yield % Related Terms

Thank you for viewing the detailed overview of Statera BioPharma's Total Payout Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Statera BioPharma (STU:7CB) Business Description

Traded in Other Exchanges
N/A
Address
4333 Corbett Drive, Suite 1082, Fort Collins, CO, USA, 80525
Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.

Statera BioPharma (STU:7CB) Headlines

No Headlines